Joschka Hey

Data-driven scientist | from confusion to understanding
@[email protected]

[Joschka Hey @HeyJosch]

I am happy to share that @NatureComms has published our latest research from the @DKFZ.

DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts

Here’s the link to the article:
https://t.co/A3VIeppqc7
👇

1/7

[Joschka Hey @HeyJosch]

@shouval Where do I need to sign to get one of those t shirts 😅?

[Joschka Hey @HeyJosch]

@MarkusMukenhirn @Dev_Cell Congratulations @MarkusMukenhirn and team 🥳

[Joschka Hey @HeyJosch]

@HauthAntonia @embl @ChromDesign @heard_lab @agnese_loda Congratulations @HauthAntonia! A well deserved finale to many years of hard work.

[DKFZ @DKFZ]

Ashish Goyal, Jens Bauer und Joschka Hey erhalten den diesjährigen #WaltraudLewenzPreis für ihre Arbeit über die Identifizierung von Neoantigenen, die von neu aktivierten Transkripten bei epigenetischen Therapien kodiert werden. Herzlichen Glückwunsch! 👏 @DKTK_

[Joschka Hey @HeyJosch]

@shouval @ddierks91 Congratulations @ddierks91!! 🎊 Have fun celebrating this major milestone!

[Anand Mayakonda 🕉️ @anand_mt]

Trackplot: a fast and minimal dependency R script for epigenomic enrichment plots

https://t.co/rMtdqum7pl

https://t.co/GusXJOfXt8

[Joschka Hey @HeyJosch]

@berlinnovation @haas_lab Congratulations @haas_lab!

[Joschka Hey @HeyJosch]

Congratulations to all authors involved in this beautiful study about Juvenile Myelomonocytic Leukemia!
I am pleased to have contributed to this work that not only demonstrates the oncofetal reprogramming of this childhood cancer, but also identifies therapeutic vulnerabilities.

[Translational Cancer Epigenomics @TransCanEpi]

Exciting findings in #childhoodcancer

#oncofetal reprogramming of postnatal #stemcells and CD52 as a novel therapeutic target in #pediatric #leukemia

New preprint from our lab by
@mp_hartmann
@MaxSchoenung
@dblipka1

https://t.co/eVL4vuZbzm

[Joschka Hey @HeyJosch]

@GuezguezL Thank you 😊

[Joschka Hey @HeyJosch]

@mllprada @Cytoreason Thank you Maria! Miss you too.

[Joschka Hey @HeyJosch]

I am happy to share that @NatureComms has published our latest research from the @DKFZ.

DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts

Here’s the link to the article:
https://t.co/A3VIeppqc7
👇

1/7

[Joschka Hey @HeyJosch]

@rn_toth @Cytoreason Thank you so much @rn_toth! This work and many other achievements would not have been possible without such a supportive office filled with good friends I had back then 😉

[Joschka Hey @HeyJosch]

@MatLupien @Sahu_B You may be interested in our latest study on treatment-induced neoantigens derived from TEs.
https://t.co/A3VIeppqc7

[Joschka Hey @HeyJosch]

@hi_stem_lab @NatureComms @DKFZ Thank you!

[DKFZ @DKFZ]

Epigenetisch wirkende Medikamente ermöglichen, dass Bereiche des Erbguts abgelesen werden, die vorher blockiert waren. Das führt zur Bildung neuer mRNA und neuer Proteine, die das Immunsystem beim Erkennen von Krebszellen unterstützen könnten. @uktuebingen
https://t.co/4YP14aRgOL

[Joschka Hey @HeyJosch]

Our main focus @Cytoreason is to utilize computational disease models to gain a better understanding of disease mechanisms, prioritize indications, and identify novel targets for various diseases.

7/7

[Joschka Hey @HeyJosch]

Although my time as a Postdoctoral Researcher at DKFZ has come to an end, I feel fortunate to have the opportunity to continue working in the same field as a Senior Bioinformatics Scientist at @Cytoreason.

6/7